As of Mar 26
| -0.0407 / -5.15%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +1,101.12% increase from the last price of 0.75.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.